EU-Startups· Rahul Raj·· 8 days agoSame newsAI Score62
SRTD Biotech raises €31.5M seed for precision mRNA therapies
Jülich-based SRTD Biotech secures €31.5 million to develop precision mRNA therapies targeting diseased cells
AI Overview
Jülich-based SRTD Biotech closed an oversubscribed €31.5M seed round led by Mérieux Equity Partners.
Same story, shown in Top Deals《SRTD Biotech raises €31.5M seed for marker-triggered RNA therapies》
Source:EU-Startups · eu-startups.com